Full-Time

Territory Sales Manager

Deadline 7/16/27
Eugia US

Eugia US

Sterile injectable medicines manufacturer

Compensation Overview

$140k - $180k/yr

+ Sales incentive + Long-term incentive plan

San Francisco, CA, USA

In Person

Requires travel within the assigned geography, including overnight travel up to 50% of the time.

Bachelor's

Category
Sales & Account Management (1)
Required Skills
CRM
Requirements
  • A bachelor's degree from an accredited four-year college or university, or equivalent experience.
  • At least 2 years of successful biotechnology or pharmaceutical sales experience.
  • A valid driver's license and an acceptable driving record.
  • Ability to travel within the assigned geography, including some overnight travel of up to 50% of the time for meetings, training events, and programs.
  • Ability to communicate clinical information in compliance with applicable pharmaceutical sales regulations, guidelines, and policies.
  • Ability to gain and sustain access, develop professional relationships with providers and their staff, and tailor the approach to each customer's needs.
  • Ability to use company-provided tools and resources to maximize territory impact.
Responsibilities
  • Initiate and expand awareness, adoption, and appropriate utilization of Acrotech's products within approved patient populations through face-to-face engagement with assigned healthcare professionals and delivery of approved brand messaging.
  • Achieve quarterly prescription-volume and volume-growth goals.
  • Meet or exceed assigned field-execution metrics, including calls per day, healthcare-professional target coverage, target reach, and target frequency.
  • Develop and execute strategic territory business plans to expand healthcare-professional prescribing for appropriate patients.
  • Partner with cross-functional teams to align on growth strategies, address customer needs, identify market opportunities and dynamics, and execute coordinated plans.
  • Develop and demonstrate expertise in the product, disease state, and market access to support appropriate product use and customer confidence.
  • Plan and execute territory- and national-level promotional programs and initiatives that support portfolio growth, drive engagement, and expand product adoption.
  • Deliver customer experiences through account management, including marketing support, product access, reimbursement navigation, and accurate on-label responses to medical inquiries.
  • Represent the company professionally, compliantly, and ethically.
  • Adhere to company and governmental compliance policies, procedures, regulations, and established safety and health protocols.
Desired Qualifications
  • Prior dermatology and/or immunology experience.
  • Demonstrated success supporting product launches.

Eugia US is a pharmaceutical company focused on generic sterile injectable medicines. Scientific, engineering, production, quality, regulatory, supply-chain, and commercial teams support the product lifecycle. It develops, manufactures, markets, and distributes institutional products used by hospitals and pharmacies. The profile is Eugia's United States operation and its institutional medicines business. Roles include formulation, manufacturing, laboratory work, validation, maintenance, quality, regulatory affairs, sales, and operations. Its workforce connects frontline delivery with the specialist, operational, technical, and business teams that support the organization.

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

New Jersey

Founded

2011

Simplify Jobs

Simplify's Take

What believers are saying

  • Pomalidomide launched March 4, 2026, expanding Eugia's U.S. oncology lineup.
  • Everolimus approval positions Unit-I for Q1 FY27 commercialization and fresh revenue.
  • Unit-I received only four FDA observations in March 2026, showing stronger compliance.

What critics are saying

  • FDA classified Eugia Unit-III OAI on June 12, 2026 after 11 findings.
  • OAI blocks pending approvals from Unit-III and delays 2026-27 injectable launches.
  • An import alert on Unit-III would cripple U.S. sterile revenue and destroy credibility.

What makes Eugia US unique

  • Eugia Pharma Specialities led Aurobindo's 184th ANDA approval on February 26, 2026.
  • Unit-I launched Pomalidomide capsules in March 2026, entering U.S. oncology generics.
  • Eugia Unit-I won Everolimus tablet approval, targeting a $78 million market.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

401(k) Company Match

Paid Vacation

Paid Holidays